Aptose Biosciences Inc. logo
Luxeptinib Preclinical Data Extend Potential Applications from Oncology to Inflammation
May 02, 2022 16:10 ET | Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly...
Aptose Biosciences Inc. logo
Aptose to Participate in Two Biotech Events in January 2022
December 29, 2021 07:30 ET | Aptose Biosciences, Inc.
— H.C. Wainwright BIOCONNECT Virtual Conference — — 11th Annual LifeSci Partners Corporate Access Event — SAN DIEGO and TORONTO, Dec. 29, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc....
Aptose Biosciences Inc. logo
Aptose Expands Senior Leadership Team
October 25, 2021 08:00 ET | Aptose Biosciences, Inc.
Janet Clennett, CPA, appointed Vice President, Finance Roger Davies, B.Sc., M. Phil, joins as Vice President, Operations SAN DIEGO and TORONTO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences...
Aptose Biosciences Inc. logo
Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021  
April 26, 2021 16:02 ET | Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, April 26, 2021 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical stage company developing highly differentiated therapeutics that target the...
Concurrent Technologies Corporation Awarded Additional $15 Million on Air Force Research Laboratory Contract
May 31, 2013 09:26 ET | Concurrent Technology Corp.
JOHNSTOWN, Pa., May 31, 2013 (GLOBE NEWSWIRE) -- Concurrent Technologies Corporation (CTC) has been awarded a $15 million increase on an Air Force Research Laboratory (AFRL) contract. The Indefinite...